MCID: ESN005
MIFTS: 51

Eosinophilic Gastroenteritis

Categories: Gastrointestinal diseases, Rare diseases

Aliases & Classifications for Eosinophilic Gastroenteritis

MalaCards integrated aliases for Eosinophilic Gastroenteritis:

Name: Eosinophilic Gastroenteritis 12 56 52 14 69
Eosinophilic Gastroenterocolitis 56
Eosinophilic Enteropathy 69
Eosinophilic Enteritis 56
Ege 56

Characteristics:

Orphanet epidemiological data:

56
eosinophilic gastroenteritis
Inheritance: Not applicable; Age of onset: All ages; Age of death: normal life expectancy;

Classifications:



Summaries for Eosinophilic Gastroenteritis

MalaCards based summary : Eosinophilic Gastroenteritis, also known as eosinophilic gastroenterocolitis, is related to gastric ulcer and lymphoma, and has symptoms including protein-losing enteropathy, hematochezia and elevated erythrocyte sedimentation rate. An important gene associated with Eosinophilic Gastroenteritis is CCL11 (C-C Motif Chemokine Ligand 11), and among its related pathways/superpathways are Innate Immune System and Response to elevated platelet cytosolic Ca2+. The drugs Budesonide and Dexlansoprazole have been mentioned in the context of this disorder. Affiliated tissues include colon, testes and small intestine.

Wikipedia : 72 Eosinophilic gastroenteritis (EG) is a rare and heterogeneous condition characterized by patchy or... more...

Related Diseases for Eosinophilic Gastroenteritis

Diseases related to Eosinophilic Gastroenteritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 178)
id Related Disease Score Top Affiliating Genes
1 gastric ulcer 30.1 ALB IL5
2 lymphoma 29.4 ALB IL5
3 asthma 27.2 CCL11 CSF2 EPX IL3 IL5 RNASE3
4 eosinophilic enteropathy 11.0
5 gastroenteritis 10.9
6 aplastic anemia 10.8
7 megalencephaly-capillary malformation-polymicrogyria syndrome, somatic 10.8
8 exercise-induced anaphylaxis 10.8
9 paroxysmal cold hemoglobinuria 10.8
10 wilms tumor 6 10.5 IL3 IL5
11 penis agenesis 10.5 CCL11 IL5
12 solitary cyst of breast 10.5 CCL11 IL5
13 dioctophymiasis 10.4 CCL11 IL5
14 cholesteatoma of middle ear 10.4 CCL11 IL5
15 epididymis adenocarcinoma 10.4 CCL11 IL5
16 antley-bixler syndrome with genital anomalies and disordered steroidogenesis 10.4 CCL11 IL5
17 papillary follicular thyroid adenocarcinoma 10.4 IL5 RNASE3
18 toxic diffuse goiter 10.4 IL5 RNASE3
19 fibrous histiocytoma 10.4 CCL11 IL5
20 marasmus 10.4 IL5 RNASE3
21 crustacean allergy 10.4 IL5 RNASE3
22 myofascial pain syndrome 10.4 CCL11 IL5
23 purpura fulminans 10.4 IL5 RNASE3
24 subacute bacterial endocarditis 10.4 IL5 RNASE3
25 exophthalmos 10.3 IL5 RNASE3
26 anterior dislocation of lens 10.3 CCL11 RNASE3
27 signet ring cell adenocarcinoma 10.3 IL5 RNASE3
28 skin disease 10.3 IL5 RNASE3
29 whistling face syndrome, recessive form 10.3 IL5 RNASE3
30 nut allergy 10.3 IL5 RNASE3
31 glioblastoma multiforme 10.2 IL5 RNASE3
32 conjunctival concretion 10.2 CCL11 IL5
33 sublingual gland cancer 10.2 IL5 RNASE3
34 esophagitis 10.2
35 duodenitis 10.2
36 primary syringomyelia 10.2 EPX RNASE3
37 dissociated nystagmus 10.2 EPX IL5
38 pancreatitis 10.1
39 cecum adenoma 10.1 EPX RNASE3
40 endotheliitis 10.1
41 fungal gastritis 10.1 CCL11 IL3 IL5
42 protein-losing enteropathy 10.1
43 cystic adventitial disease 10.1 CSF2 IL3
44 clostridium difficile colitis 10.1 EPX RNASE3
45 neutropenia, severe congenital 3, autosomal recessive 10.1 CSF2 IL3
46 neutropenia, severe congenital 1, autosomal dominant 10.1 CSF2 IL3
47 mucositis 10.1
48 x-linked intellectual disability, van esch type 10.1 IL3 IL5 RNASE3
49 orbital plasma cell granuloma 10.0 IL3 IL5 RNASE3
50 lymphangiectasia, intestinal 10.0 CSF2 IL3

Graphical network of the top 20 diseases related to Eosinophilic Gastroenteritis:



Diseases related to Eosinophilic Gastroenteritis

Symptoms & Phenotypes for Eosinophilic Gastroenteritis

Human phenotypes related to Eosinophilic Gastroenteritis:

56 32 (show all 19)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 protein-losing enteropathy 56 32 occasional (7.5%) Occasional (29-5%) HP:0002243
2 hematochezia 56 32 occasional (7.5%) Occasional (29-5%) HP:0002573
3 elevated erythrocyte sedimentation rate 56 32 occasional (7.5%) Occasional (29-5%) HP:0003565
4 anemia 56 32 frequent (33%) Frequent (79-30%) HP:0001903
5 leukocytosis 56 32 frequent (33%) Frequent (79-30%) HP:0001974
6 vomiting 56 32 frequent (33%) Frequent (79-30%) HP:0002013
7 dysphagia 56 32 frequent (33%) Frequent (79-30%) HP:0002015
8 abdominal pain 56 32 frequent (33%) Frequent (79-30%) HP:0002027
9 steatorrhea 56 32 frequent (33%) Frequent (79-30%) HP:0002570
10 hypoalbuminemia 56 32 frequent (33%) Frequent (79-30%) HP:0003073
11 allergic rhinitis 56 32 frequent (33%) Frequent (79-30%) HP:0003193
12 elevated c-reactive protein level 56 32 frequent (33%) Frequent (79-30%) HP:0011227
13 edema 56 32 occasional (7.5%) Occasional (29-5%) HP:0000969
14 atopic dermatitis 56 32 occasional (7.5%) Occasional (29-5%) HP:0001047
15 ascites 56 32 occasional (7.5%) Occasional (29-5%) HP:0001541
16 weight loss 56 32 occasional (7.5%) Occasional (29-5%) HP:0001824
17 asthma 56 32 occasional (7.5%) Occasional (29-5%) HP:0002099
18 diarrhea 56 Frequent (79-30%)
19 malabsorption 56 Frequent (79-30%)

Drugs & Therapeutics for Eosinophilic Gastroenteritis

Drugs for Eosinophilic Gastroenteritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 108)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Budesonide Approved Phase 4,Phase 3,Phase 2 51333-22-3 63006 5281004
2
Dexlansoprazole Approved Phase 4,Phase 2,Phase 1 138530-94-6, 103577-45-3 9578005
3
Lansoprazole Approved, Investigational Phase 4,Phase 2,Phase 1 103577-45-3 3883
4
Menthol Approved Phase 4 2216-51-5 16666
5 Anti-Asthmatic Agents Phase 4,Phase 3,Phase 2,Phase 1
6 Cromolyn Sodium Phase 4
7 Respiratory System Agents Phase 4,Phase 3,Phase 2,Phase 1
8 Anti-Allergic Agents Phase 4,Phase 3,Phase 2,Phase 1
9 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
10 Autonomic Agents Phase 4,Phase 3,Phase 2
11 Bronchodilator Agents Phase 4,Phase 3,Phase 2
12 Dermatologic Agents Phase 4,Phase 3,Phase 2
13
Fluticasone Phase 4,Phase 3,Phase 2 90566-53-3, 80474-14-2 62924 22833648
14 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1
15 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
16 Hormones Phase 4,Phase 3,Phase 2,Phase 1
17 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
18 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2
19 Antacids Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
20 Anti-Ulcer Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
21 Gastrointestinal Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
22
Proton pump inhibitors Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
23 Olive Nutraceutical Phase 4
24 Soy Bean Nutraceutical Phase 4,Phase 2,Phase 3
25
Montelukast Approved Phase 3,Phase 1 158966-92-8 5281040
26
Esomeprazole Approved, Investigational Phase 2, Phase 3 161796-78-7, 119141-88-7 4594 9579578
27 Leukotriene Antagonists Phase 3,Phase 1
28
Omalizumab Approved, Investigational Phase 2,Phase 1 242138-07-4
29
Infliximab Approved Phase 2 170277-31-3
30
Losartan Approved Phase 2 114798-26-4 3961
31
Bethanechol Approved Phase 2 674-38-4 2370
32
Angiotensin II Investigational Phase 2 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
33 Antibodies Phase 2,Phase 1
34 Antibodies, Monoclonal Phase 2,Phase 1
35 Immunoglobulins Phase 2,Phase 1
36 Indoleacetic Acids Phase 2
37 Antirheumatic Agents Phase 2
38 interferons Phase 1, Phase 2
39 Neurotransmitter Agents Phase 2
40 Pharmaceutical Solutions Phase 2
41 Angiotensin II Type 1 Receptor Blockers Phase 2
42 Angiotensin Receptor Antagonists Phase 2
43 Angiotensinogen Phase 2
44 Anti-Arrhythmia Agents Phase 2
45 Antihypertensive Agents Phase 2
46 Vasoconstrictor Agents Phase 2
47 mometasone furoate Phase 2 83919-23-7
48 Cholinergic Agents Phase 2
49
Lactulose Approved Phase 1 4618-18-2 11333
50
Mannitol Approved, Investigational Phase 1 69-65-8 453 6251

Interventional clinical trials:

(show top 50) (show all 118)

id Name Status NCT ID Phase Drugs
1 Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis Unknown status NCT02371941 Phase 4 oral cromolyn sodium;Placebo
2 Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis Unknown status NCT01846962 Phase 4 Budesonide;Fluticasone
3 Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis Recruiting NCT02019758 Phase 4 Oral Viscous Budesonide;Fluticasone MDI;Placebo slurry;Placebo inhaler
4 The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors Terminated NCT01404832 Phase 4 Treat with lansoprazole 30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms
5 Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis Completed NCT00635089 Phase 3 reslizumab
6 Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years Completed NCT00538434 Phase 2, Phase 3
7 Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis Completed NCT02434029 Phase 3 Budesonide 1mg orodispersible tablet twice daily;Placebo orodispersible tablet twice daily
8 A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders Completed NCT00266578 Phase 3 Fluticasone Propionate
9 The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis Completed NCT00728481 Phase 2, Phase 3 Esomeprazole;Budesonide
10 Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis Recruiting NCT02493335 Phase 3 Budesonide 0.5mg orodispersible tablet twice daily;Budesonide 1mg orodispersible tablet twice daily;Placebo orodispersible tablet twice daily
11 Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE) Recruiting NCT03245840 Phase 3 Budesonide oral suspension
12 A Placebo- Controlled Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved Recruiting NCT02605837 Phase 3 OBS;Placebo
13 An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE) Recruiting NCT02736409 Phase 3 Oral Budesonide Suspension (OBS);Placebo
14 Eosinophilic Esophagitis (EoE) Intervention Trial-Randomized 1 Food Elimination vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids Recruiting NCT02610816 Phase 2, Phase 3 Flovent (fluticasone propionate)
15 SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study Recruiting NCT02778867 Phase 2, Phase 3 Flovent
16 Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone Active, not recruiting NCT01702701 Phase 3 Montelukast;Fluticasone
17 Safety and Efficacy of Three Doses of Oral Fluticasone Propionate in Adults With Eosinophilic Esophagitis Not yet recruiting NCT02873468 Phase 2, Phase 3 EMS Fluticasone 1;EMS Fluticasone 2;EMS Fluticasone 3
18 A Study of Flovent in Patients With Eosinophilic Esophagitis Completed NCT00426283 Phase 2 Flovent
19 Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis Completed NCT00762073 Phase 2 budesonide;placebo
20 Budesonide for Eosinophilic Esophagitis Completed NCT00271349 Phase 2 Budesonide
21 Topical Steroid Treatment for Eosinophilic Esophagitis Completed NCT00275561 Phase 2 Fluticasone;Placebo
22 Omalizumab to Treat Eosinophilic Gastroenteritis Completed NCT00084097 Phase 2 Omalizumab
23 Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis Completed NCT00638456 Phase 2 Budesonide plus Prevacid;placebo plus Prevacid
24 Proof of Concept Study of OC000459 in Eosinophilic Esophagitis Completed NCT01056783 Phase 2 OC000459;Placebo
25 Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis Completed NCT02098473 Phase 2 RPC4046;Placebo
26 Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis Completed NCT02280616 Phase 2 low dose budesonide tablet;high dose budesonide tablet;high dose budesonide suspension;Placebo
27 Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis Completed NCT01386112 Phase 1, Phase 2 EUR-1100;placebo
28 Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis Completed NCT01022970 Phase 2 QAX576 placebo;QAX576
29 Study of Dupilumab in Adult Patients With Active Eosinophilic Esophagitis (EoE) Completed NCT02379052 Phase 2 Dupilumab;Placebo
30 A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab Completed NCT00123630 Phase 2 omalizumab;Placebo
31 Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis Completed NCT00123656 Phase 2 esomeprazole;fluticasone
32 Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis Completed NCT00523354 Phase 2 Infliximab
33 OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension Completed NCT01642212 Phase 2 Oral Budesonide Suspension (MB-9);Placebo
34 An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients Completed NCT00274703 Phase 2 mepolizumab
35 Intravenous Mepolizumab In Children With Eosinophilic Esophagitis Completed NCT00358449 Phase 2 mepolizumab
36 Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome Completed NCT00017862 Phase 2 SCH55700
37 Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome Completed NCT00266565 Phase 1, Phase 2 Mepolizumab
38 Eosinophilic Esophagitis Clinical Therapy Comparison Trial Recruiting NCT01821898 Phase 2 Oral Budesonide
39 Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) Recruiting NCT03191864 Phase 2 APT-1011;Placebo
40 An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) Recruiting NCT03029091 Phase 2 Losartan Potassium
41 Milk Patch for Eosinophilic Esophagitis Active, not recruiting NCT02579876 Phase 2 Viaskin Milk 500 mcg;Viaskin Placebo
42 Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD Active, not recruiting NCT01808196 Phase 2 Losartan Potassium
43 Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study. Enrolling by invitation NCT02113267 Phase 2 Mometasone furoate;Placebo
44 Bethanechol for Eosinophilic Esophagitis Terminated NCT02058537 Phase 2 Bethanechol
45 Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Withdrawn NCT01479231 Phase 1, Phase 2 dexlansoprazole
46 Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplication (TIF) Using EsophyX for the Treatment of GERD Withdrawn NCT01025739 Phase 2
47 Observational Field Study of Acute Esophageal Food Bolus Impaction by Mean Esophageal Manometry and 24h-pH-monitoring Unknown status NCT01447823 Phase 1
48 Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients Completed NCT01641913 Phase 1
49 Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model Completed NCT01040598 Phase 1
50 Trial of Montelukast in Eosinophilic Esophagitis Completed NCT00511316 Phase 1 Montelukast/ Singulair;Placebo

Search NIH Clinical Center for Eosinophilic Gastroenteritis

Genetic Tests for Eosinophilic Gastroenteritis

Anatomical Context for Eosinophilic Gastroenteritis

MalaCards organs/tissues related to Eosinophilic Gastroenteritis:

39
Colon, Testes, Small Intestine, T Cells, Liver, Lymph Node, Bone

Publications for Eosinophilic Gastroenteritis

Articles related to Eosinophilic Gastroenteritis:

(show top 50) (show all 391)
id Title Authors Year
1
Eosinophilic gastroenteritis presenting as upper gastrointestinal hematoma and ulcers after endoscopic biopsy: A case report and literature review. ( 28906408 )
2017
2
Eosinophilic Gastroenteritis Presenting with Red Streaking. ( 28250308 )
2017
3
Eosinophilic gastroenteritis caused by eating hens' eggs: A case report. ( 28279648 )
2017
4
Post-partum eosinophilic gastroenteritis: A case report. ( 28081983 )
2017
5
Lack of Knowledge and Low Readiness for Health Care Transition in Eosinophilic Esophagitis and Eosinophilic Gastroenteritis. ( 28644350 )
2017
6
Eosinophilic gastroenteritis: three clinical cases with different presentations. ( 28063615 )
2017
7
CCR3 Monoclonal Antibody Inhibits Eosinophilic Inflammation and Mucosal Injury in a Mouse Model of Eosinophilic Gastroenteritis. ( 28497923 )
2017
8
Prevalence of Eosinophilic Gastroenteritis and Colitis in a Population-Based Study, From 2012 to 2017. ( 28603057 )
2017
9
Hematemesis as Initial Presentation in a 10-Week-Old Infant with Eosinophilic Gastroenteritis. ( 28299223 )
2017
10
Diagnosis of eosinophilic gastroenteritis is easily missed. ( 28596692 )
2017
11
Serum Biomarkers for the Diagnosis of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis. ( 28943560 )
2017
12
Eosinophilic gastroenteritis in a teenager: A rare diagnosis. ( 27283450 )
2017
13
Eosinophilic gastroenteritis in a woman with multiple sclerosis on dimethyl fumarate. ( 27466473 )
2016
14
Eosinophilic gastroenteritis in a patient with Bruton's tyrosine kinase deficiency. ( 26840762 )
2016
15
Sera of patients with infantile eosinophilic gastroenteritis showed a specific increase in both thymic stromal lymphopoietin and IL-33 levels. ( 26948075 )
2016
16
Eosinophilic gastroenteritis: Approach to diagnosis and management. ( 27867684 )
2016
17
Eosinophilic gastroenteritis: A state-of-the-art review. ( 27253425 )
2016
18
Eosinophilic Gastroenteritis: An Underdiagnosed Condition. ( 27234270 )
2016
19
Lack of Knowledge and Low Readiness for Healthcare Transition in Eosinophilic Esophagitis and Eosinophilic Gastroenteritis. ( 27657884 )
2016
20
Eosinophilic gastroenteritis: a challenge to diagnose and treat. ( 27613263 )
2016
21
Severe Eosinophilic Gastroenteritis in a Crohn's Disease Patient Treated With Infliximab and Adalimumab. ( 27018120 )
2016
22
Severe eosinophilic gastroenteritis. ( 26802190 )
2016
23
A Case of Eosinophilic Gastroenteritis Forming a Rigid Chamber Mimicking Giant Duodenal Ulcer on Computed Tomography Imaging. ( 27086704 )
2016
24
Eosinophilic gastroenteritis in an 18-year-old male with prolonged nephrotic syndrome. ( 28018451 )
2016
25
Eosinophilic Gastroenteritis as a Rare Cause of Recurrent Epigastric Pain. ( 27274524 )
2016
26
Eosinophilic gastroenteritis due to rhus ingestion presenting with gastrointestinal hemorrhage. ( 25844348 )
2015
27
Eosinophilic Gastroenteritis: Case Report and Review in Search for Diagnostic Key Points. ( 26075112 )
2015
28
Eosinophilic Gastroenteritis with Ascites in a Child. ( 26388635 )
2015
29
Perforated duodenal ulcer: An unusual manifestation of allergic eosinophilic gastroenteritis. ( 26640348 )
2015
30
A Case of Eosinophilic Gastroenteritis with Ascites. ( 26819619 )
2015
31
Eosinophilic gastroenteritis due to egg allergy presenting as acute pancreatitis. ( 25668683 )
2015
32
Systematic Review: The Efficacy of Dietary Treatment for Inducing Disease Remission in Eosinophilic Gastroenteritis. ( 25699593 )
2015
33
Eosinophilic gastroenteritis and bowel obstruction. Can surgery be avoided? ( 25733047 )
2015
34
The management of eosinophilic gastroenteritis. ( 26027839 )
2015
35
Differences in Features and Course of Mucosal Type Eosinophilic Gastroenteritis between Korean Infants and Children. ( 26240491 )
2015
36
Clinical Manifestations and Treatment Outcomes of Eosinophilic Gastroenteritis in Children. ( 26770900 )
2015
37
Eosinophilic gastroenteritis: Clinical profiles and treatment outcomes, a retrospective study of 18 adult patients in a Singapore Tertiary Hospital. ( 26358020 )
2015
38
Eosinophilic gastroenteritis after allogeneic bone marrow transplantation. ( 25913480 )
2015
39
A case of a teenage boy with eosinophilic gastroenteritis with esophageal involvement developing a hemorrhagic duodenal ulcer. ( 26037474 )
2015
40
Eosinophilic Gastroenteritis and Colitis: a Comprehensive Review. ( 26054822 )
2015
41
Milk-sensitive eosinophilic gastroenteritis in a 2-month-old boy. ( 26272958 )
2015
42
Proton pump inhibitor treatment decreased duodenal and esophageal eosinophilia in a case of eosinophilic gastroenteritis. ( 26344087 )
2015
43
Obstructive eosinophilic gastroenteritis in a patient with rheumatoid arthritis. ( 26264946 )
2015
44
A Case of Proton Pump Inhibitor-Resistant Multiple Gastric Ulcers Caused by Eosinophilic Gastroenteritis. ( 26272422 )
2015
45
Eosinophilic gastroenteritis mimicking as a malignant gastric ulcer with lymphadenopathy as shown by computed tomography and endoscopic ultrasound. ( 25789292 )
2015
46
An Atypical Case of Eosinophilic Gastroenteritis Presenting as Hypovolemic Shock. ( 26078733 )
2015
47
Clinical characteristics, treatment outcomes, and resource utilization in children and adults with eosinophilic gastroenteritis. ( 25547198 )
2015
48
Eosinophilic gastroenteritis as an unusual manifestation of multiple mesenteric lymph node enlargements and recurrent diarrheas. ( 26006212 )
2015
49
Eosinophilic gastroenteritis associated with eosinophilic cystitis: Computed tomography and magnetic resonance imaging findings. ( 25780317 )
2015
50
Allergic Bronchopulmonary Aspergillosis Associated With Eosinophilic Gastroenteritis. ( 26727774 )
2015

Variations for Eosinophilic Gastroenteritis

Expression for Eosinophilic Gastroenteritis

Search GEO for disease gene expression data for Eosinophilic Gastroenteritis.

Pathways for Eosinophilic Gastroenteritis

Pathways related to Eosinophilic Gastroenteritis according to GeneCards Suite gene sharing:

(show all 18)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.61 CCL11 CSF2 EPX IL3 IL5 RNASE3
2
Show member pathways
12.95 ALB CSF2 IL3 IL5
3
Show member pathways
12.92 CCL11 CSF2 IL3 IL5
4
Show member pathways
12.23 CSF2 IL3 IL5
5
Show member pathways
12.09 CCL11 EPX IL3 IL5 RNASE3
6
Show member pathways
12 CCL11 CSF2 IL5
7
Show member pathways
11.89 CSF2 IL3 IL5
8
Show member pathways
11.82 CSF2 IL3 IL5
9 11.68 CSF2 IL3 IL5
10 11.57 CSF2 IL3 IL5
11 11.49 CSF2 IL5
12
Show member pathways
11.43 CSF2 IL3 IL5
13 11.35 CCL11 IL5
14 11.3 CCL11 CSF2 IL5
15 11.18 CCL11 IL5
16 11.11 CSF2 IL3 IL5
17 10.69 CCL11 CSF2 IL3 IL5
18 10.28 CSF2 IL3 IL5

GO Terms for Eosinophilic Gastroenteritis

Cellular components related to Eosinophilic Gastroenteritis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.5 ALB CCL11 CSF2 EPX IL3 IL5
2 extracellular space GO:0005615 9.17 ALB CCL11 CSF2 EPX IL3 IL5

Biological processes related to Eosinophilic Gastroenteritis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 positive regulation of GTPase activity GO:0043547 9.56 CCL11 CSF2 IL3 IL5
2 MAPK cascade GO:0000165 9.5 CSF2 IL3 IL5
3 cellular oxidant detoxification GO:0098869 9.43 ALB EPX
4 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.4 CSF2 IL3
5 positive regulation of DNA replication GO:0045740 9.37 CSF2 IL3
6 peptidyl-tyrosine phosphorylation GO:0018108 9.33 CSF2 IL3 IL5
7 immune response GO:0006955 9.26 CCL11 CSF2 IL3 IL5
8 positive regulation of podosome assembly GO:0071803 8.62 CSF2 IL5

Molecular functions related to Eosinophilic Gastroenteritis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protein tyrosine kinase activity GO:0004713 9.43 CSF2 IL3 IL5
2 growth factor activity GO:0008083 9.33 CSF2 IL3 IL5
3 Ras guanyl-nucleotide exchange factor activity GO:0005088 9.13 CSF2 IL3 IL5
4 cytokine activity GO:0005125 8.92 CCL11 CSF2 IL3 IL5

Sources for Eosinophilic Gastroenteritis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....